Organization Overview
Historical Acquisition Tree
Alternative names
lucinactant (surfaxin) (2012 NDA)
Key: Windtree Therapeutics (0) Acquired (1)
Key: Windtree Therapeutics (1) Acquired (3)
Key: Windtree Therapeutics (0) Acquired (1)
Acute Lung Injury (Phase 2)
Birth Weight (Phase 2)
Bronchopulmonary Dysplasia (Phase 2)
Cystic Fibrosis (Phase 2)
Fibrosis (Phase 2)
Lung Diseases (Phase 2)
Lung Injury (Phase 2)
Meconium Aspiration Syndrome (Phase 3)
Premature Birth (Phase 2)
Pulmonary Fibrosis (Phase 2)
Respiratory Distress Syndrome (Phase 2)
Respiratory Distress Syndrome, Newborn (Phase 2)
Respiratory Insufficiency (Phase 2)
Shock (Phase 2)
Shock, Cardiogenic (Phase 2)
Syndrome (Phase 2)